97 related articles for article (PubMed ID: 15321732)
1. High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury.
Colpaert FC; Wu WP; Hao JX; Royer I; Sautel F; Wiesenfeld-Hallin Z; Xu XJ
Eur J Pharmacol; 2004 Aug; 497(1):29-33. PubMed ID: 15321732
[TBL] [Abstract][Full Text] [Related]
2. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist.
Deseure K; Bréand S; Colpaert FC
Eur J Pharmacol; 2007 Jul; 568(1-3):134-41. PubMed ID: 17512927
[TBL] [Abstract][Full Text] [Related]
3. Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain.
Deseure K; Koek W; Adriaensen H; Colpaert FC
J Pharmacol Exp Ther; 2003 Aug; 306(2):505-14. PubMed ID: 12730352
[TBL] [Abstract][Full Text] [Related]
4. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning.
Colpaert FC; Deseure K; Stinus L; Adriaensen H
J Pharmacol Exp Ther; 2006 Feb; 316(2):892-9. PubMed ID: 16254131
[TBL] [Abstract][Full Text] [Related]
5. The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury.
Wu WP; Hao JX; Xu XJ; Wiesenfeld-Hallin Z; Koek W; Colpaert FC
Eur J Pharmacol; 2003 Oct; 478(2-3):131-7. PubMed ID: 14575797
[TBL] [Abstract][Full Text] [Related]
6. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters.
Bardin L; Assié MB; Pélissou M; Royer-Urios I; Newman-Tancredi A; Ribet JP; Sautel F; Koek W; Colpaert FC
J Pharmacol Exp Ther; 2005 Mar; 312(3):1034-42. PubMed ID: 15528450
[TBL] [Abstract][Full Text] [Related]
7. 5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief.
Colpaert FC
Curr Opin Investig Drugs; 2006 Jan; 7(1):40-7. PubMed ID: 16425670
[TBL] [Abstract][Full Text] [Related]
8. Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury.
Hao JX; Stöhr T; Selve N; Wiesenfeld-Hallin Z; Xu XJ
Eur J Pharmacol; 2006 Dec; 553(1-3):135-40. PubMed ID: 17092498
[TBL] [Abstract][Full Text] [Related]
9. Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model: a c-Fos study.
Buritova J; Larrue S; Aliaga M; Besson JM; Colpaert F
Eur J Pharmacol; 2005 May; 514(2-3):121-30. PubMed ID: 15910798
[TBL] [Abstract][Full Text] [Related]
10. The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes.
You HJ; Colpaert FC; Arendt-Nielsen L
Exp Neurol; 2005 Jan; 191(1):174-83. PubMed ID: 15589524
[TBL] [Abstract][Full Text] [Related]
11. The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain.
Kiss I; Degryse AD; Bardin L; Gomez de Segura IA; Colpaert FC
Eur J Pharmacol; 2005 Oct; 523(1-3):29-39. PubMed ID: 16226246
[TBL] [Abstract][Full Text] [Related]
12. Effects of the combined continuous administration of morphine and the high-efficacy 5-HT1A agonist, F 13640 in a rat model of trigeminal neuropathic pain.
Deseure KR; Adriaensen HF; Colpaert FC
Eur J Pain; 2004 Dec; 8(6):547-54. PubMed ID: 15531223
[TBL] [Abstract][Full Text] [Related]
13. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
14. The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury.
Oatway MA; Chen Y; Weaver LC
Pain; 2004 Jul; 110(1-2):259-68. PubMed ID: 15275776
[TBL] [Abstract][Full Text] [Related]
15. Effect of spinal cord stimulation in an animal model of neuropathic pain relates to degree of tactile "allodynia".
Smits H; Ultenius C; Deumens R; Koopmans GC; Honig WM; van Kleef M; Linderoth B; Joosten EA
Neuroscience; 2006 Dec; 143(2):541-6. PubMed ID: 16978792
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the 5-HT3 receptor for days causes sustained relief from mechanical allodynia following spinal cord injury.
Chen Y; Oatway MA; Weaver LC
J Neurosci Res; 2009 Feb; 87(2):418-24. PubMed ID: 18798253
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT(1A) receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain.
Deseure K; Koek W; Colpaert FC; Adriaensen H
Eur J Pharmacol; 2002 Dec; 456(1-3):51-7. PubMed ID: 12450569
[TBL] [Abstract][Full Text] [Related]
18. Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia.
Colpaert FC; Tarayre JP; Koek W; Pauwels PJ; Bardin L; Xu XJ; Wiesenfeld-Hallin Z; Cosi C; Carilla-Durand E; Assié MB; Vacher B
Neuropharmacology; 2002 Nov; 43(6):945-58. PubMed ID: 12423664
[TBL] [Abstract][Full Text] [Related]
19. Contralateral neuropathic pain and neuropathology in dorsal root ganglion and spinal cord following hemilateral nerve injury in rats.
Hatashita S; Sekiguchi M; Kobayashi H; Konno S; Kikuchi S
Spine (Phila Pa 1976); 2008 May; 33(12):1344-51. PubMed ID: 18496347
[TBL] [Abstract][Full Text] [Related]
20. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
